Progress in Neuro-Psychopharmacology and Biological Psychiatry
Genetic influences of dopamine transport gene on alcohol dependence: A pooled analysis of 13 studies with 2483 cases and 1753 controls
Introduction
Alcohol dependence is one of the most prevalent mental health problems in the USA. The prevalence of lifetime and 12-month alcohol dependence in the USA was 12.5% and 3.8% (Hasin et al., 2007). Estimation of genetic effects on alcohol dependence is as high as 50 to 70% in both men and women, as is shown by numerous twin and adoption studies (Goldman et al., 2005, Pagan et al., 2006). In attempts to identify the genetic risks for alcohol dependence, genes involved in dopaminergic system have been paid much attention during the past twenty years. As is known, alcohol may activate the dopaminergic system, which in turn is associated with positive reinforcement (Berridge and Robinson, 1998). Therefore, genetic variants regulating genes coding for proteins involved in dopamine neurotransmission might account for different responses to alcohol or might contribute to individual variation in alcohol dependence (Persico et al., 1993).
Essential in dopamine regulation is the dopamine transporter (DAT1, gene symbol: SLC6A3). SLC6A3 is a 12-membrane domain Na+/Cl−-dependent transport protein, with the responsibility for the reuptake of extracellular synaptic dopamine into presynaptic neurons, and hereby termination of dopaminergic neurotransmission (Giros et al., 1992). As such, dopaminergic reward circuits are likely to function differently with different expression levels of SLC6A3 (Drgon et al., 2006), which implies the SLC6A3 gene is a potential candidate in clinical studies on alcohol dependence.
The biological mechanism under which SLC6A3 availability is regulated in the brain is still unclear. Brain imaging studies discover that SLC6A3 expression levels may be affected by alcohol consumption. Two studies reported that SLC6A3 levels were significantly lower in the striatum of alcohol-dependent humans and monkeys than in controls, but returned to normal levels after a period of abstinence (Laine et al., 1999, Mash et al., 1996). While two other studies did not find reductions in SLC6A3 levels in the brains of alcoholics when compared with controls (Heinz et al., 1998, Volkow et al., 1996), although this might be related to the fact that measurements were carried out up to several weeks after withdrawal of alcohol, in which the expression levels of SLC6A3 may have already returned to normal.
The availability of SLC6A3 in the brain may be dependent on genetic variation. SLC6A3 gene is mapped on chromosome 5p15.3 with 15 exons separated by 14 introns spanning more than 65 kb. The protein-coding portion begins within exon 2 and ends near the beginning of exon 15 (Banno et al., 2001). This coding region presents strong conservation and the polymorphisms within the coding region represent either silent nucleotide changes or rare conservative amino acid substitutions (Grünhage et al., 2000), indicating that individual differences in SLC6A3 expression must arise from regulatory sequences. Lin and Uhl (2003) observed the effects of protein-coding variants V55A and V382A in the human dopamine transporter gene on expression and uptake activities in vitro. Drgon et al. (2006) reported common human 5′ dopamine transporter haplotypes yield varying expression levels in vivo. Greenwood and Kelsoe (2003) identified a strong core promoter extending from − 251 to + 63 in the genomic sequence of the SLC6A3 gene and suggested the presence of repressor elements in the 5′-upstream region and within intron 1(Xu et al., 2010).
The genetic polymorphism of interest in most genetic association studies on alcohol dependence, however, is a variable number of tandem repeats (VNTR) of 40 bp in the 3′ un-translation region. For the VNTR, numbers ranging from 3 to 16 have been described, with the 9- and 10-repeat alleles being the most common variants (Banno et al., 2001, Vandenbergh et al., 1992). Several studies have demonstrated ethnic differences in SLC6A3 VNTR frequency distributions (Kang et al., 1999, Mitchell et al., 2000). The results of human genetic association studies investigating the relationship between this VNTR and alcohol dependence have been equivocal. Since the VNTR is located in the 3′-UTR of the gene, outside the open reading frame of the gene, allelic variants do not result in structural or functional differences in the SLC6A3 protein. Nonetheless, research suggests that the SLC6A3 VNTR is able to regulate specific gene functioning by influencing levels of expression. As such, SLC6A3 expression may be influenced by alteration in the length or sequence of the VNTR (Conne et al., 2000). It is also likely that this VNTR is in linkage disequilibrium with other susceptibility loci within the gene. A SNP in the 3′-UTR of SLC6A3 consists of a G to A mutation at position 2319 in SLC6A3 cDNA has also been investigated with the association of alcohol dependence by Ueno et al., 1999a, Ueno et al., 1999b, Choi et al., 2006a, Choi et al., 2006b, but the two studies with limited sample size reported conflicting results.
To identify a real association, we performed pooled analysis of multicenter genetic association studies to determine whether the failure to identify any real association is attributable to: 1) the low power of individual studies to detect a small effect; 2) etiological heterogeneity arose from potential confounding factors.
Section snippets
Data collection
To identify studies eligible for this collaborative analysis, we conducted a computerized search on Medline and the Chinese National Knowledge Infrastructure Database from 1995 up to August 2010. Keywords used were ‘dopamine transporter’, ‘DAT1’, ‘DAT’, ‘SLC6A3’, combined with ‘alcohol’, ‘dependence’ and ‘alcoholism’. We also used reference lists from identified articles and reviews to find additional original reports not indexed by the search engine.
Data synthesis
Only those studies examining at least one
Results
The application of foregoing criteria yielded 23 studies (Ueno et al., 1999a, Ueno et al., 1999b, Choi et al., 2006a, Choi et al., 2006b, Muramatsu and Higuchi, 1995, Sander et al., 1997, Dobashi et al., 1997, Parsian and Zhang, 1997, Schmidt et al., 1998, Franke et al., 1999, Ueno et al., 1999a, Ueno et al., 1999b, Vandenbergh et al., 2000, Heinz et al., 2000, Bau et al., 2001, Chen et al., 2001, Wernicke et al., 2002, Gorwood et al., 2003, Limosin et al., 2004, Foley et al., 2004, Köhnke et
Discussion
The results of this combined-analysis indicate that the 9- and 10-repeat alleles of the 40-base-pair VNTR of the SLC6A3 gene are not associated with alcohol dependence. The pooled OR for the 9-repeat allele was 0.99, and the OR for the 10-repeat allele was 1.00. None of the analyses reached statistical significance, in spite of a power greater than 80% to detect a significant OR as small as 1.3. Lack of significance attributable to the negative effects of single large studies or to
Contributors
Mingqing Xu and Z. Carl Lin initiated and designed the study. Mingqing Xu collected and analyzed the data, and drafted the manuscript. All investigators contributed to the interpretation, and revision.
Funding/Support
This work was supported by the U.S.A. National Institutes of Health grant R01DA021409.
Role of the Funding Source
The sponsors of the study had no role in the study design, data collection, data analysis, data interpretation or writing of the report.
Acknowledgements
We are grateful to all the investigators who kindly provided their original data to us in this project.
Conflict of Interest Statement
None declared.
References (55)
- et al.
What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience
Brain Res Rev
(1998) - et al.
Genetic polymorphisms of alcohol and aldehyde dehydrogenase, dopamine and serotonin transporters in familial and non-familial alcoholism
Eur Neuropsychopharmacol
(2006) - et al.
Genetic polymorphisms of alcohol and aldehyde dehydrogenase, dopamine and serotonin transporters in familial and non-familial alcoholism
Eur Neuropsychopharmacol
(2006) - et al.
Meta-analysis in clinical trials
Control Clin Trials
(1986) - et al.
DAT1 gene polymorphism in alcoholism: a family-based association study
Biol Psychiatry
(1999) - et al.
Meta-analysis shows schizophrenia is not associated with the 40-base-pair repeat polymorphism of the dopamine transporter gene
Schizophr Res
(2005) - et al.
The A9 allele of the dopamine transporter gene is associated with delirium tremens and alcohol-withdrawal seizure
Biol Psychiatry
(2003) - et al.
Promoter and intronic variants affect the transcriptional regulation of the human dopamine transporter gene
Genomics
(2003) - et al.
Genotype influences in vivo dopamine transporter availability in human striatum
Neuropsychopharmacology
(2000) - et al.
Promoter specific methylation of the dopamine transporter gene is altered in alcohol dependence and associated with craving
J Psychiatr Res
(2009)
Global variation of a 40-bp VNTR in the 3′-untranslated region of the dopamine transporter gene (SLC6A3)
Biol Psychiatry
The A9 allele of the dopamine transporter gene increases the risk of visual hallucinations during alcohol withdrawal in alcohol-dependent women
Neurosci Lett
Dopamine transporter gene polymorphism and alcoholism
Biochem Biophys Res Commun
Dopamine transporter gene polymorphisms are not associated with polysubstance abuse
Biol Psychiatry
Allelic association of a dopamine transporter gene polymorphism in alcohol dependence with withdrawal seizures or delirium
Biol Psychiatry
Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR
Genomics
Evidence for the importance of the human dopamine transporter gene for withdrawal symptomatology of alcoholics in a German population
Neurosci Lett
Convergent evidence shows a positive association of interleukin-1 gene complex locus with susceptibility to schizophrenia in the Caucasian population
Schizophr Res
Meta-analysis of association between ApoE epsilon4 allele and schizophrenia
Schizophr Res
Brain-derived neurotrophic factor gene C-270 T and Val66Met functional polymorphisms and risk of schizophrenia: a moderate-scale population-based study and meta-analysis
Schizophr Res
The human dopamine transporter gene: gene organization, transcriptional regulation, and potential involvement in neuropsychiatric disorders
Eur Neuropsychopharmacol
Haploview: analysis and visualization of LD and haplotype maps
Bioinformatics
DRD4 and DAT1 as modifying genes in alcoholism: interaction with novelty seeking on level of alcohol consumption
Mol Psychiatry
Genetic polymorphisms of the promoter region of dopamine D2 receptor and dopamine transporter genes and alcoholism among four aboriginal groups and Han Chinese in Taiwan
Psychiatr Genet
The 3′ untranslated region of messenger RNA: a molecular ‘hotspot’ for pathology?
Nat Med
Alcoholism and gene polymorphisms related to central dopaminergic transmission in the Japanese population
Psychiatr Genet
Common human 5′ dopamine transporter (SLC6A3) haplotypes yield varying expression levels in vivo
Cell Mol Neurobiol
Cited by (31)
Genetics of alcohol use disorder
2019, Personalized PsychiatryEnvironmental risks outweigh dopaminergic genetic risks for alcohol use and abuse from adolescence through early adulthood
2017, Drug and Alcohol DependenceCitation Excerpt :A number of studies have found positive links between the number of 10-repeats and alcohol use among youth, although patterns across age and sex are inconsistent (Guo et al., 2007, 2010; Hopfer et al., 2005; Schmid et al., 2009; Vaske et al., 2009). However, meta-analyses of primarily small clinical adult samples have not detected associations with alcohol dependence (Du et al., 2011; Xu and Lin, 2011; but see Ma et al., 2016). A number of dopamine receptor genes have also been linked to alcohol use.
Meta-analysis of six genes (BDNF, DRD1, DRD3, DRD4, GRIN2B and MAOA) involved in neuroplasticity and the risk for alcohol dependence
2015, Drug and Alcohol DependenceAssociation of gene polymorphisms encoding dopaminergic system components and platelet MAO-B activity with alcohol dependence and alcohol dependence-related phenotypes
2014, Progress in Neuro-Psychopharmacology and Biological PsychiatryCitation Excerpt :Due to its position, DAT VNTR has no impact on the protein structure, but many functional effects on gene expression have been reported (Haddley et al., 2008) and the 10R allele is thought to be associated with higher levels of DAT expression (VanNess et al., 2005). The association between DAT VNTR and addictive behavior, such as tobacco smoking (Barr et al., 2001; Timberlake et al., 2006) was found, while a lack of association between DAT VNTR and alcohol dependence (Xu and Lin, 2011) has also been reported. Dopamine beta-hydroxylase (DBH) catalyzes the conversion of dopamine to norepinephrine.
SLC6A3 is a risk factor for Parkinson's disease: A meta-analysis of sixteen years' studies
2014, Neuroscience LettersCitation Excerpt :Studies on at least one genetic marker in the SLC6A3 gene were included in this meta-analysis [2,3]. In addition, selected studies met all of the following criteria [47]: (1) from a peer-reviewed journal; (2) reporting original data on allele/genotype frequencies, and no genotype frequencies deviated from Hardy–Weinberg equilibrium (HWE) among control subjects (p > 0.01); (3) independence from other studies (without sharing of any data with another reported studies, all that included and re-analyzed a previously published data set were not regarded as independent and in such cases, only the study composed of the largest sample size and the most detailed information was included in the meta-analysis); and (4) case–control studies. From each study, we collected information on publication year and authors, sample location, demography including age-at-diagnosis and -onset, cohort size, and genetic (allele and genotype) composition.